Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]
News [4645]
Articles [192]
Editorials [8]
Conferences [136]
elearning [9]
Researchers repurpose immune-activating cytokine to fight breast cancer
Researchers repurpose immune-activating cytokine to fight breast cancer
Cancer immunotherapy may work better in patients with specific genes
Cancer immunotherapy may work better in patients with specific genes
First-in-class ERK1/2 inhibitor safe, shows early efficacy in advanced solid tumours
First-in-class ERK1/2 inhibitor safe, shows early efficacy in advanced solid tumours
'Bet hedging' explains the efficacy of many combination cancer therapies
'Bet hedging' explains the efficacy of many combination cancer therapies
Blueprints for anti-cancer drugs discovered in bacterial genomes
Blueprints for anti-cancer drugs discovered in bacterial genomes
Recommendations for genetic counselling and genetic testing for hereditary prostate cancer
Recommendations for genetic counselling and genetic testing for hereditary prostate cancer
Scientists discover possible master switch for programming cancer immunotherapy
Scientists discover possible master switch for programming cancer immunotherapy
Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy
Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy
ASH 2017: AML study reports high response rates with combination targeted therapy
ASH 2017: AML study reports high response rates with combination targeted therapy
NICE recommends lenvatinib for the treatment of advanced renal cell carcinoma (RCC)
NICE recommends lenvatinib for the treatment of advanced renal cell carcinoma (RCC)

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation